Follow us for regular updates on cell analysis technology news, events, and more.
ACEA Biosciences, a part of Agilent Technologies, is a pioneer in the development and commercialization of high performance cell analysis platforms for life science research. ACEA’s xCELLigence® Real-Time Cell Analysis instruments and NovoCyte® aQuanteon flow cytometers are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research. More than 2,500 instruments have been placed globally, and have been used in more than 1,800 peer-reviewed publications.
Investors 2
Date | Name | Website |
- | Qiming Ven... | qimingvent... |
- | Qiming Ven... | qimingvc.c... |